CEACAM5 and colorectal adenocarcinoma: Patients with colorectal adenocarcinoma had significantly higher serum CA19-9, CA125, CEA levels than controls(P < 0.05), the high density group was more significantly increased than the low density group (P < 0.05), See Table 8.